JKAP relates to disease risk, severity, and Th1 and Th17 differentiation in Parkinson's disease
Abstract Objective JNK pathway‐associated phosphatase (JKAP) is previously reported to regulate immune/inflammatory process via T‐cell signaling, and closely involves in neurological diseases, while its implication in Parkinson's disease (PD) is unknown. Therefore, this study aimed to investiga...
Enregistré dans:
Auteurs principaux: | Qingwei Yang, Jingcong Zhuang, Pingping Cai, Longling Li, Rong Wang, Zhongjie Chen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7de7c38244e44b79a65f18954214a270 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity
par: Laurie K. Mischley, et autres
Publié: (2017) -
Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
par: Abigail L. Pfaff, et autres
Publié: (2021) -
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
par: Luca Baldelli, et autres
Publié: (2021) -
Delayed orthostatic hypotension in Parkinson’s disease
par: Sang-Won Yoo, et autres
Publié: (2021) -
Imaging Parkinson’s disease below the neck
par: Per Borghammer, et autres
Publié: (2017)